• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Model Number NV UNK PIPELINE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Intracranial Hemorrhage (1891); Ischemia (1942)
Event Date 11/02/2020
Event Type  Injury  
Event Description
Luo, b., kang, h., zhang, h., li, t., liu, j., song, d., zhao, y., guan, s., maimaitili, a., wang, y., feng, w., wang, y., wan, j., mao, g., shi, h., yang, x.(2020).Pipeline embolization device for intracranial aneurysms in a large chinese cohort: factors related to aneurysm occlusion.Therapeutic advances in neurological disorders, 13, 1756286420967828.Https://doi.Org/10.1177/1756286420967828.Medtronic review of the literature article found a multi-center study to investigate the safety and effectiveness of the pipeline embolization device (ped) for treatment of intracranial aneurysms in the chinese population.1171 patients with 1322 intracranial aneurysms treated in 1319 procedures were included in the study.The average patient age was 53.9 ± 11.4 years and the majority of patient's included in the study were female (69.4%).685 aneurysms were treated with ped only and 637 aneurysms were treated with ped plus coiling.85 patients had post-operative ischemic complications.24 patients had subarachnoid hemorrhage post-operatively.23 patients had int raparenchymal hemorrhage post-operatively.
 
Manufacturer Narrative
Reported patient age ((b)(6)) is representative of the mean age of all patients included in the study.Reported patient sex (female) is representative of the majority of patients included in the study.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key13446096
MDR Text Key285250685
Report Number2029214-2022-00152
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 02/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/03/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNV UNK PIPELINE
Device Catalogue NumberNV UNK PIPELINE
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/28/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age53 YR
Patient SexFemale
Patient RaceAsian
-
-